Month of CIRM: Reviewing Review

Dr. Gil Sambrano, Vice President, Portfolio & Review All month, we’ve used our blog and social channels to highlight a new chapter in CIRM’s life after Proposition 14. We’re looking back at our work since 2004 and ahead to what's next. Today, we spotlight CIRM's Portfolio & Review team. Most drivers never think about what … Continue reading Month of CIRM: Reviewing Review

CIRM Board invests $5 million in emergency funding for coronavirus

Coronavirus In response to the crisis caused by the COVID-19 virus in California and around the world the governing Board of the California Institute for Regenerative Medicine (CIRM) today held an emergency meeting to approve $5 million in rapid research funds targeting the virus. “These are clearly extraordinary times and they require an extraordinary response … Continue reading CIRM Board invests $5 million in emergency funding for coronavirus

CIRM-funded medical research and development company does $150M deal to improve care for dialysis patients

Nearly half a million Americans with kidney disease are on dialysis, so it’s not surprising the CIRM Board had no hesitation, back in July 2016, in funding a program to make it easier and safer to get that life-saving therapy. That's why it’s gratifying to now hear that Humacyte, the company behind this new dialysis … Continue reading CIRM-funded medical research and development company does $150M deal to improve care for dialysis patients

Mark Noble a pioneer in stem cell research

Mark Noble. Photo by Todd Dubnicoff Mark Noble, Ph.D., is a pioneer in stem cell research and the Director of the University of Rochester Stem Cell and Regenerative Medicine Institute in New York. He is also a member of CIRM’s Grants Working Group (GWG), the panel of independent scientific experts we use to review research … Continue reading Mark Noble a pioneer in stem cell research

CIRM 2017, A year of accelerating stem cell treatments

At CIRM we have our focus very clearly on the future, on accelerating stem cell therapies to patients with unmet medical needs. But every once in a while, it’s a good idea to look back at what you have already done. Knowing where you came from can help you get to where you are heading. … Continue reading CIRM 2017, A year of accelerating stem cell treatments